Discontinued — last reported Q3 '25
West Pharmaceutical Services Operating Lease Liability Payments Due increased by 31.2% to $140.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.4%, from $113.70M to $140.30M. Over 3 years (FY 2020 to FY 2023), Operating Lease Liability Payments Due shows an upward trend with a 11.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Rising liabilities indicate growing operational footprint or lease renewals, while falling liabilities may signal cost-cutting or consolidation of facilities.
This represents the total future cash payments required for operating leases, typically categorized by maturity periods...
Standardized under ASC 842, this metric is highly comparable across all public companies with significant physical operations.
operating_lease_liability_payments_due| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $78.60M | $74.10M | $86.40M | $93.70M | $95.20M | $104.40M | $126.70M | $123.20M | $119.90M | $115.50M | $118.10M | $115.70M | $119.90M | $116.40M | $113.70M | $113.50M | $106.90M | $140.30M |
| QoQ Change | — | -5.7% | +16.6% | +8.4% | +1.6% | +9.7% | +21.4% | -2.8% | -2.7% | -3.7% | +2.3% | -2.0% | +3.6% | -2.9% | -2.3% | -0.2% | -5.8% | +31.2% |
| YoY Change | — | — | — | — | +21.1% | +40.9% | +46.6% | +31.5% | +25.9% | +10.6% | -6.8% | -6.1% | +0.0% | +0.8% | -1.7% | -5.3% | -8.2% | +23.4% |